During the past decade, Dokkyo Medical University Saitama Medical Center conducted 25 clinical trials. In the 10-year time frame, 25 clinical trials started and 6 clinical trials were completed, i.e. on average, 24% percent of trials that started reached the finish line to date. In the past 5 years, 17 clinical trials started and 6 clinical trials were completed. i.e. 35.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Dokkyo Medical University Saitama Medical Center" #1 sponsor was "Janssen Research & Development, LLC" with 7 trials, followed by "Merck Sharp & Dohme LLC" with 3 trials sponsored, "Shire" with 3 trials sponsored, "Chugai Pharmaceutical" with 2 trials sponsored and "Incyte Corporation" with 2 trials sponsored. Other sponsors include 4 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Dokkyo Medical University Saitama Medical Center" #1 collaborator was "Japan Lung Cancer Society" with 2 trials as a collaborator and "Korean Gynecologic Oncology Group" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Dokkyo Medical University Saitama Medical Center" are "Prostatic Neoplasms" (5 trials), "Ulcerative Colitis" (3 trials), "Urothelial Cancer" (3 trials), "Myelofibrosis" (2 trials) and "Post Essential Thrombocythemia Myelofibrosis" (2 trials). Many other conditions were trialed in "Dokkyo Medical University Saitama Medical Center" in a lesser frequency.

Most popular intervention types in "Dokkyo Medical University Saitama Medical Center" are "Drug" (19 trials), "Biological" (5 trials), "Other" (4 trials), "Device" (2 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (9 trials), "Pembrolizumab" (4 trials), "Dexamethasone" (3 trials), "Docetaxel" (3 trials) and "Enzalutamide" (3 trials). Other intervention names were less common.

The vast majority of trials in "Dokkyo Medical University Saitama Medical Center" are 20 trials for "All" genders, 5 trials for "Male" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Dokkyo Medical University Saitama Medical Center". undefined are not yet recruiting, 12 are recruiting, 8 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Dokkyo Medical University Saitama Medical Center, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Dokkyo Medical University Saitama Medical Center, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 18 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".